Can-Fite BioPharma CANF
NYSE CANF
$2.19 -0.03 (-1.34%)
As of: Sep 10, 2026 · 9:36 AM EDT

Can-Fite BioPharma (CANF) Prepaid Assets (2016 - 2026)

Can-Fite BioPharma (CANF) posted Prepaid Assets of $960000.0 for Q2 2026, up 6.67% quarter-over-quarter from $900000.0 in Q4 2025, and down 17.81% YoY from $1.2 million in Q2 2025.

Analysis

Can-Fite BioPharma (CANF) Prepaid Assets (2016 - 2026) Analysis & Trends

Can-Fite BioPharma (CANF) has 11 years of Prepaid Assets data on file, last reported at $960000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 17.81% year-over-year to $960000.0; the trailing twelve-month figure through Jun 2026 stood at $960000.0 (down 17.81% YoY), and the FY2025 full-year result was $900000.0, down 17.81% from the prior year.
  • Prepaid Assets was $960000.0 for Q2 2026 at Can-Fite BioPharma, up from $900000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q2 2022 to a low of $900000.0 in Q4 2025.
  • A 5-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Prepaid Assets.
  • Across the five-year window, Prepaid Assets surged 116.03% in 2022 and tumbled 35.96% in 2023, its largest moves.
  • Can-Fite BioPharma's Prepaid Assets stood at $1.2 million in 2022, then decreased by 15.73% to $986000.0 in 2023, then increased by 11.05% to $1.1 million in 2024, then dropped by 17.81% to $900000.0 in 2025, then gained by 6.67% to $960000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $960000.0 in Q2 2026, $900000.0 in Q4 2025, and $1.2 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.12 Bn 628.36 Bn 17.26 Bn
2 AbbVie 445.86 Bn 439.29 Bn 12.70 Bn
3 Merck 362.13 Bn 354.99 Bn 12.21 Bn
4 Novartis Ag 268.88 Bn 261.19 Bn 11.24 Bn
5 Pfizer 156.96 Bn 145.26 Bn 10.94 Bn
6 Sanofi 52.26 Bn 44.88 Bn 10.79 Bn
7 Revolution Medicines 42.98 Bn 42.98 Bn -
8 Incyte 25.13 Bn 20.59 Bn 1.57 Bn
9 United Therapeutics 21.56 Bn 18.90 Bn 683.80 Mn
10 Can-Fite BioPharma 1.80 Mn -1.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 960,000.00
Dec 31, 2025 900,000.00
Jun 30, 2025 1.17 Mn
Dec 31, 2024 1.10 Mn
Jun 30, 2024 1.10 Mn
Dec 31, 2023 986,000.00
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.29 Mn
Mar 31, 2023 962,000.00
Dec 31, 2022 1.17 Mn
Sep 30, 2022 1.75 Mn
Jun 30, 2022 1.82 Mn
Mar 31, 2022 971,000.00
Dec 31, 2021 929,000.00
Sep 30, 2021 811,000.00
Jun 30, 2021 1.75 Mn
Mar 31, 2021 1.02 Mn
Dec 31, 2020 1.06 Mn
Jun 30, 2020 3.57 Mn
Dec 31, 2019 4.38 Mn